---
title: "Amfetamine - Attention deficit hyperactivity disorder - 2"
sidebar: mydoc_sidebar
permalink: db00182-mesh-d001289-2.html
toc: false 
---


Path ID: `DB00182_MESH_D001289_2`
{% include image.html url="images/db00182-mesh-d001289-2.png" file="db00182-mesh-d001289-2.png" alt="db00182-mesh-d001289-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000661 | amfetamine | Drug |
| InterPro:IPR001613 | monoamine oxidase | Protein |
| GO:0005739 | mitochondria | CellularComponent |
| MESH:D018377 | neurotransmitters | ChemicalSubstance |
| MESH:D001289 | Attention deficit hyperactivity disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Amfetamine | DECREASES ACTIVITY OF | Monoamine Oxidase |
| Monoamine Oxidase | LOCATED IN | Mitochondria |
| Mitochondria | INCREASES ABUNDANCE OF | Neurotransmitters |
| Neurotransmitters | REGULATES | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00182#mechanismofaction](https://go.drugbank.com/drugs/DB00182#mechanismofaction)
